Complete Metabolic Health Panel - Comprehensive Metabolic Assessment

First-line tests for suspected pancreatic inflammation. Lipase is more pancreas-specific while amylase rises quickly. Simple, low-cost, and easy to interpret.

Complete pancreatic assessment including enzymes, glucose metabolism, insulin function, liver/biliary markers, inflammation, and metabolic risk factors.

Insulin resistance often develops silently—long before blood sugar levels appear abnormal on routine tests. The Insulin Resistance Panel is designed to detect early metabolic dysfunction by evaluating how your body produces and responds to insulin, not just your glucose levels alone. By combining HbA1c, fasting glucose, fasting insulin, C-peptide, and a Comprehensive Metabolic Panel (CMP), this panel provides a deeper, more accurate picture of insulin sensitivity and metabolic health. C-peptide adds an important layer of insight by showing how much insulin your pancreas is actually producing, helping distinguish between insulin resistance, early beta-cell stress, and other metabolic patterns that glucose testing alone can miss. This panel is ideal for individuals experiencing unexplained weight gain, fatigue, sugar cravings, or difficulty losing weight, as well as those with a family history of diabetes, metabolic syndrome, or cardiovascular risk. Identifying insulin resistance early allows for timely lifestyle or medical interventions and may help prevent progression to prediabetes or type 2 diabetes. Testing is completed at Quest Diagnostics locations nationwide, with fast, reliable results to help you take a proactive step toward better metabolic health.